N/A
Completed N=15
Enhanced Community-Based Asthma Monitoring Through Novel Technology
Source: ClinicalTrials.gov NCT05824936 ↗Enrolled (actual)
15
Serious AEs
0.0%
Results posted
May 2025
Primary outcomePrimary: Feasibility (Retention %) — 14 Participants
Summary
The goal of this pilot interventional study is to learn about the implementation of a home monitoring program (using remote study visits and lung function testing) in children with asthma.
The main questions to answer are:
1. Do participants find the program to be feasible, acceptable and accessible?
2. What factors are associated with completion of the program?
3. Does the program have an effect on asthma control and daytime sleepiness?
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility (Retention %) |
14 | — |
| PRIMARY Acceptability |
12; 12; 12; 12; 12; 11 | — |
| PRIMARY Accessibility |
9; 61 | — |
| SECONDARY Explore the Preliminary Effectiveness of the Pilot Program on Asthma Control. |
23; 22 | — |
| SECONDARY Explore the Preliminary Effectiveness of the Pilot Program on Daytime Sleepiness. |
6; 4 | — |
| SECONDARY Explore Patient and Family-related Demographic Characteristics and Psychosocial Factors Associated With Successful Completion of the Intervention. |
3; 0; 11; 1; 4; 1 | — |
| SECONDARY Explore Asthma-related Factors Associated With Successful Completion of the Intervention (Oral Steroid Usage) |
1; 0 | — |
| SECONDARY Explore Asthma-related Factors Associated With Successful Completion of the Intervention (ER Visits) |
1; 0 | — |
| SECONDARY Explore Asthma-related Factors Associated With Successful Completion of the Intervention (Hospital Admissions) |
0; 0 | — |
Eligibility Criteria
Inclusion Criteria
- Followed by a Primary Care Practice meeting HRSA rural or medically underserved designation status
- Diagnosis of persistent asthma: on at least 1 controller/ preventative medication for asthma
- Ability to follow directions and perform study measures, including in-office spirometry at initial visit
- Access to mobile device with internet connectivity to connect to telehealth visit and mobile spirometer application
Exclusion Criteria
- Significant cardiopulmonary disease other than asthma (Examples: Cystic Fibrosis, complex congenital heart disease)
- Non-English Speaking
Data sourced from ClinicalTrials.gov (NCT05824936). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.